Mindray's New TE7 Max Ultrasound System Expands Possibilities for Point of Care
|
By MedImaging International staff writers Posted on 27 Oct 2021 |

Mindray North America (Mahwah, NJ, USA) has launched its new TE7 Max ultrasound system that maximizes the potential of ultrasound in the Point of Care (POC) market.
The TE7 Max has a 21.5 inch vertically oriented high-definition LED display and a sealed touch-based interface to maximize what clinicians can see. Designed to exceed the requirements of demanding POC environments, the system provides best-in-class image quality and a superior user experience during rapid clinical assessments and procedures. Unlike traditional POC ultrasound machines (POCUS), the TE7 Max provides clinicians with comprehensive and customizable workflow protocols (iWorks™) and an extensive suite of artificial intelligence (AI) powered Smart Tools, all in a compact footprint so they can quickly move from patient-to-patient prioritizing efficiency, reproducibility, and quality for all end-users.
Using AI-powered Smart Tools (Smart B-Line, Smart VTI, Smart IVC), the portable ultrasound system can help assess volume status and fluid responsiveness in critically ill patients. With advanced applications (Smart FHR, Smart Bladder, Auto EF), the TE7 Max can help clinicians during rapid clinical assessments and procedures at patients' bedside or on the go. It is also equipped with the most advanced suite of needle-guidance technologies (eSpacial Navi™ 4D Magnetic Needle Navigation Technology and iNeedle+™) to help streamline workflow and improve accuracy with needle-guided procedures.
The slim cart and large screen beautifully display Mindray's leading-edge technologies and everyday applications that meet the diverse, evolving demands of POC environments. Additionally, the TE7 Max ultrasound machine is backed by Mindray's exclusive Living Technology™ promise that provides customers with easily upgradable software enhancements to secure product investment protection and keep their ultrasound machines at the leading edge of imaging performance excellence throughout the product's life cycle.
"Five years ago, Mindray set a new standard for Point of Care ultrasound with the launch of the TE7," said Maher Elhihi, Mindray's Sr. Director of Marketing, Ultrasound. "That system was truly ahead of its time, and today many of our competitors have tried to emulate. As a leader in Emergency Medicine ultrasound, it is our responsibility to push the technology forward, and the new TE7 Max raises the bar yet again and empowers our customers to provide the highest quality of care now and in the future."
Related Links:
Mindray North America
Latest Ultrasound News
- New Ultrasound AI Tool Supports Rapid Prenatal Assessment
- New Consensus Standardizes Ultrasound-Based Fatty Liver Assessment
- Groundbreaking Technology to Enhance Precision in Emergency and Critical Care
- Reusable Gel Pad Made from Tamarind Seed Could Transform Ultrasound Examinations
- AI Model Accurately Detects Placenta Accreta in Pregnancy Before Delivery
- Portable Ultrasound Sensor to Enable Earlier Breast Cancer Detection
- Portable Imaging Scanner to Diagnose Lymphatic Disease in Real Time
- Imaging Technique Generates Simultaneous 3D Color Images of Soft-Tissue Structure and Vasculature
- Wearable Ultrasound Imaging System to Enable Real-Time Disease Monitoring
- Ultrasound Technique Visualizes Deep Blood Vessels in 3D Without Contrast Agents
- Ultrasound Probe Images Entire Organ in 4D

- Disposable Ultrasound Patch Performs Better Than Existing Devices
- Non-Invasive Ultrasound-Based Tool Accurately Detects Infant Meningitis
- Breakthrough Deep Learning Model Enhances Handheld 3D Medical Imaging
- Pain-Free Breast Imaging System Performs One Minute Cancer Scan
- Wireless Chronic Pain Management Device to Reduce Need for Painkillers and Surgery
Channels
Radiography
view channel
AI Boosts Breast Cancer Detection and Cuts Screening Workload
Breast cancer screening programs face rising demand and persistent workforce shortages, straining double-reading workflows and delaying care. Early detection is critical to reduce mortality and minimize... Read more
AI Tool Predicts Breast Cancer Risk Years Ahead Using Routine Mammograms
Breast cancer screening saves lives but still relies largely on uniform schedules despite wide differences in individual risk. This one-size-fits-all approach can miss cancers in higher-risk women while... Read moreMRI
view channel
MRI-Based AI Tool Supports Differentiation of Parkinsonian Syndromes
Clinicians often struggle to differentiate Parkinsonian syndromes at initial presentation, when symptom overlap can obscure disease trajectory and delay targeted care. Imaging markers derived from diffusion... Read more
MRI-Derived Biomarker Improves Risk Stratification in Glioblastoma
Glioblastoma is marked by rapid growth and diffuse infiltration that complicate prognosis and treatment planning. Clinicians need objective tools that capture both how these tumors expand and how they... Read more
Combined Imaging Approach Identifies Cause of Heart Attack without Coronary Blockage
Patients who present with myocardial infarction but show no obstructive coronary disease often leave without a definitive diagnosis. That uncertainty complicates in-hospital decision-making and post-discharge... Read moreNuclear Medicine
view channel
PET Tracer Enables Noninvasive Measurement of Beta Cell Mass
Type 1 diabetes is an autoimmune disease in which the immune system destroys insulin-producing pancreatic beta cells. Loss of these cells destabilizes glucose control and drives complications.... Read more
New Imaging Tool Sheds Light on Tumor Fat Metabolism
Rapidly growing tumors reprogram metabolism to meet high energy demands. While many cancers preferentially consume glucose, lipid utilization by malignant cells is difficult to measure in living subjects.... Read more
Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies
Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read moreGeneral/Advanced Imaging
view channel
AI Tool Predicts Side Effects from Lung Cancer Treatment
Radiation therapy is a central treatment for lung cancer, but even carefully targeted radiation can affect surrounding healthy tissue. Patients may develop side effects such as lung inflammation, coughing,... Read more
AI Tool Offers Prognosis for Patients with Head and Neck Cancer
Oropharyngeal cancer is a form of head and neck cancer that can spread through lymph nodes, significantly affecting survival and treatment decisions. Current therapies often involve combinations of surgery,... Read moreImaging IT
view channel
Breast Imaging Software Enhances Visualization and Tissue Characterization in Challenging Cases
Breast imaging can be particularly challenging in cases involving small breasts or implants, where image reconstruction and tissue characterization may be limited. Clinicians also need reproducible analysis... Read more
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read moreIndustry News
view channel
Nuclear Medicine Set for Continued Growth Driven by Demand for Precision Diagnostics
Clinical imaging services face rising demand for precise molecular diagnostics and targeted radiopharmaceutical therapy as cancer and chronic disease rates climb. A new market analysis projects rapid expansion... Read more







